Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2026-03-03 @ 6:46 PM
Study NCT ID:
NCT01729806
Status:
COMPLETED
Last Update Posted:
2018-04-11
First Post:
2012-11-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-14
First Submit QC Date:
None
Study First Post Date:
2012-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-10
Last Update Post Date:
2018-04-11
Last Update Post Date Type:
ACTUAL